Inside Lupus Ventures and the Push to Fund Cures First
Lupus has long been one of medicine’s most complex and underfunded diseases. Now, with a stronger clinical pipeline and growing industry interest, Lupus Ventures is stepping in to close the funding gap and prioritize return on mission over return on capital.